Micelle-based activatable probe for in vivo near-infrared optical imaging of cancer biomolecules

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 1, 2014, Pages 187-195

  Shimizu, Yoichi ^a,b   Temma, Takashi ^a   Hara, Isao ^c   Makino, Akira ^a   Yamahara, Ryo ^c   Ozeki, Ei ichi ^c   Ono, Masahiro ^a   Saji, Hideo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c SHIMADZU CORPORATION   (Japan)

Author keywords

Activatable probe; Lactosome; Molecular imaging; Near infrared fluorescence imaging; Polymeric micelle

Indexed keywords

FLUORESCENT PROBES; LACTOSOME; NEAR-INFRARED FLUORESCENCE IMAGING; NEAR-INFRARED OPTICAL IMAGING; POLYMER MICELLES; POLYMERIC MICELLE; SINGLE-CHAIN ANTIBODIES; TISSUE INTERFERENCE;

ANTIBODIES; BIOCHEMISTRY; BIOMOLECULES; DIAGNOSIS; FLUORESCENCE; INFRARED DEVICES; MICELLES; MOLECULAR IMAGING; OPTICAL IMAGE STORAGE; POLYMERS; TUMORS;

PROBES;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2 SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; FLUORESCENT DYE; MALEIMIDE; POLYMER; POLYSARCOSINE BLOCK POLY LEVO LACTATE; SELF ASSEMBLED MONOLAYER; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; DENATURATION; DISSOCIATION CONSTANT; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LYSOSOME; MICELLE; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NANOENCAPSULATION; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; PARTICLE SIZE; PHOTOCHEMICAL QUENCHING; PROTEIN EXPRESSION; SCID MOUSE; TUMOR DIAGNOSIS; TUMOR XENOGRAFT;

MUS;

ACTIVATABLE PROBE; LACTOSOME; MOLECULAR IMAGING; NEAR-INFRARED FLUORESCENCE IMAGING; POLYMERIC MICELLE;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; HUMANS; MICE; MICELLES; MICROSCOPY, FLUORESCENCE; RECEPTOR, ERBB-2; SPECTROSCOPY, NEAR-INFRARED;

EID: 84890981360     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.06.009     Document Type: Article

References (42)

1. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
2. Mendelsohn J., Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003, 21:2787-2799.
3. Gindy M.E., Prud'homme R.K. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 2009, 6:865-878.
4. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
5. Kobayashi H., Ogawa M., Alford R., Choyke P.L., Urano Y. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev 2010, 110:2620-2640.
6. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001, 19:316-317.
7. Shimizu Y., Temma T., Hara I., Yamahara R., Ozeki E., Ono M., et al. Development of novel nanocarrier-based near-infrared optical probes for in vivo tumor imaging. J Fluoresc 2012, 22:719-727.
8. Makino A., Yamahara R., Ozeki E., Kimura S. Preparation of novel polymer assemblies, "lactosome", composed of poly(l-lactic acid) and poly(sarcosine). Chem Lett 2007, 36:1220-1221.
9. Makino A., Kizaka-Kondoh S., Yamahara R., Hara I., Kanzaki T., Ozeki E., et al. Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(l-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Biomaterials 2009, 30:5156-5160.
10. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
11. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde A., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001, 344:783-792.
12. Hendriks B.S., Opresko L.K., Wiley H.S., Lauffenburger D. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. Cancer Res 2003, 63:1130-1137.
13. Worn A., Pluckthun A. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly. FEBS Lett 1998, 427:357-361.
14. Bravman T., Bronner V., Lavie K., Notcovich A., Papalia G.A., Myszka D.G. Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal Biochem 2006, 358:281-288.
15. Kim J.W., Kim H.P., Im S.A., Kang S., Hur H.S., Yoon Y.K., et al. The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. Cancer Lett 2008, 272:296-306.
16. Steinhauser I., Spankuch B., Strebhardt K., Langer K. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials 2006, 27:4975-4983.
17. West W., Pearce S. The dimeric state of cyanine dyes. J Phys Chem 1965, 69:1894-1903.
18. Vigor K.L., Kyrtatos P.G., Minogue S., Al-Jamal K.T., Kogelberg H., Tolner B., et al. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 2010, 31:1307-1315.
19. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
20. Sahoo S.K., Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003, 8:1112-1120.
21. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006, 66:6732-6740.
22. Cho H., Indig G.L., Weichert J., Shin H.C., Kwon G.S. In vivo cancer imaging by poly(ethylene glycol)-b-poly(varepsilon-caprolactone) micelles containing a near-infrared probe. Nanomedicine: NBM 2012, 8:228-236.
23. Harari D., Yarden Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 2000, 19:6102-6114.
24. Osenkowski P., Toth M., Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol 2004, 200:2-10.
25. Shimizu Y., Temma T., Sano K., Ono M., Saji H. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection. Cancer Sci 2011, 102:1897-1903.
26. Leamon C.P., Low P.S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci U S A 1991, 88:5572-5576.
27. Eiblmaier M., Meyer L.A., Watson M.A., Fracasso P.M., Pike L.J., Anderson C.J. Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines. J Nucl Med 2008, 49:1472-1479.
28. Hopkins C.R., Trowbridge I.S. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J Cell Biol 1983, 97:508-521.
29. Tromberg B.J., Cerussi A., Shah N., Compton M., Durkin A., Hsiang D., et al. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005, 7:279-285.
30. Polom K., Murawa D., Rho Y.S., Nowaczyk P., Hunerbein M., Murawa P. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer 2011, 117:4812-4822.
31. Yamamoto Y., Nagasaki Y., Kato Y., Sugiyama Y., Kataoka K. Long-circulating poly(ethylene glycol)-poly(d, l-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001, 77:27-38.
32. Xiao K., Li Y., Luo J., Lee J.S., Xiao W., Gonik A.M., et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011, 32:3435-3446.
33. Koide Y., Urano Y., Hanaoka K., Terai T., Nagano T. Evolution of group 14 rhodamines as platforms for near-infrared fluorescence probes utilizing photoinduced electron transfer. ACS Chem Biol 2011, 6:600-608.
34. Luo S., Zhang E., Su Y., Cheng T., Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011, 32:7127-7138.
35. Wang Y., Chen L. Quantum dots, lighting up the research and development of nanomedicine. Nanomedicine: NBM 2011, 7:385-402.
36. Derfus A.M., Chan C.W.C., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
37. Murphy C.J., Gole A.M., Stone J.W., Sisco P.N., Alkilany A.M., Goldsmith E.C., et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008, 41:1721-1730.
38. Papagiannaros A., Levchenko T., Hartner W., Mongayt D., Torchilin V. Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region. Nanomedicine: NBM 2009, 5:216-224.
39. Hoshino A., Manabe N., Fujioka K., Suzuki K., Yasuhara M., Yamamoto K. Use of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicity. J Artif Organs 2007, 10:149-157.
40. Simpson C.A., Salleng K.J., Cliffel D.E., Feldheim D.L. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine: NBM 2013, 9:257-263.
41. Gupta B., Revagadea N., Hilbornb J. Poly(lactic acid) fiber: an overview. Prog Polym Sci 2007, 32:455-482.
42. Tsai G., Lane H.Y., Yang P., Chong M.Y., Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 2004, 55:452-456.